1040P Phase I study of IL-8 inhibitor AMY109 plus atezolizumab (atezo) in patients (pts) with advanced solid tumours

Autor: Kuboki, Y., Kitano, S., Ikeda, M., Koyama, T., Mizugaki, H., Narikiyo, T., Yamaguchi, Y., Ishida, T., Takubo, R., Ogami, C., Sekiya, M., Nakagawa, Y., Yamamoto, N.
Zdroj: In Annals of Oncology October 2023 34 Supplement 2:S631-S632
Databáze: ScienceDirect